Cargando…

Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation

Background: Body composition parameters are reported to influence the risk of hepatocellular carcinoma (HCC) recurrence after liver resection, yet data on patients undergoing liver transplantation are scarce. The aim of this study was to evaluate the impact of the amount of abdominal adipose tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Grąt, Karolina, Pacho, Ryszard, Grąt, Michał, Krawczyk, Marek, Zieniewicz, Krzysztof, Rowiński, Olgierd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832484/
https://www.ncbi.nlm.nih.gov/pubmed/31614892
http://dx.doi.org/10.3390/jcm8101672
_version_ 1783466183548207104
author Grąt, Karolina
Pacho, Ryszard
Grąt, Michał
Krawczyk, Marek
Zieniewicz, Krzysztof
Rowiński, Olgierd
author_facet Grąt, Karolina
Pacho, Ryszard
Grąt, Michał
Krawczyk, Marek
Zieniewicz, Krzysztof
Rowiński, Olgierd
author_sort Grąt, Karolina
collection PubMed
description Background: Body composition parameters are reported to influence the risk of hepatocellular carcinoma (HCC) recurrence after liver resection, yet data on patients undergoing liver transplantation are scarce. The aim of this study was to evaluate the impact of the amount of abdominal adipose tissue and skeletal muscles on the risk of HCC recurrence after liver transplantation. Methods: This was a retrospective observational study performed on 77 HCC patients after liver transplantation. Subcutaneous fat area (SFA), visceral fat area, psoas muscle area and total skeletal muscle area were assessed on computed tomography on the level of L3 vertebra and divided by square meters of patient height. The primary outcome measure was five-year recurrence-free survival. Results: Recurrence-free survival in the entire cohort was 95.7%, 90.8%, and 86.5% after one, three, and five years post-transplantation, respectively. SFA was significantly associated with the risk of HCC recurrence (p = 0.013), whereas no significant effects were found for visceral fat and skeletal muscle indices. The optimal cut-off for SFA for prediction of recurrence was 71.5 cm(2)/m(2). Patients with SFA < 71.5 cm(2)/m(2) and ≥71.5 cm(2)/m(2) exhibited five-year recurrence-free survival of 96.0% and 55.4%, respectively (p = 0.001). Conclusions: Excessive amount of subcutaneous adipose tissue is a risk factor for HCC recurrence after liver transplantation and may be considered in patient selection process.
format Online
Article
Text
id pubmed-6832484
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68324842019-11-25 Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation Grąt, Karolina Pacho, Ryszard Grąt, Michał Krawczyk, Marek Zieniewicz, Krzysztof Rowiński, Olgierd J Clin Med Article Background: Body composition parameters are reported to influence the risk of hepatocellular carcinoma (HCC) recurrence after liver resection, yet data on patients undergoing liver transplantation are scarce. The aim of this study was to evaluate the impact of the amount of abdominal adipose tissue and skeletal muscles on the risk of HCC recurrence after liver transplantation. Methods: This was a retrospective observational study performed on 77 HCC patients after liver transplantation. Subcutaneous fat area (SFA), visceral fat area, psoas muscle area and total skeletal muscle area were assessed on computed tomography on the level of L3 vertebra and divided by square meters of patient height. The primary outcome measure was five-year recurrence-free survival. Results: Recurrence-free survival in the entire cohort was 95.7%, 90.8%, and 86.5% after one, three, and five years post-transplantation, respectively. SFA was significantly associated with the risk of HCC recurrence (p = 0.013), whereas no significant effects were found for visceral fat and skeletal muscle indices. The optimal cut-off for SFA for prediction of recurrence was 71.5 cm(2)/m(2). Patients with SFA < 71.5 cm(2)/m(2) and ≥71.5 cm(2)/m(2) exhibited five-year recurrence-free survival of 96.0% and 55.4%, respectively (p = 0.001). Conclusions: Excessive amount of subcutaneous adipose tissue is a risk factor for HCC recurrence after liver transplantation and may be considered in patient selection process. MDPI 2019-10-13 /pmc/articles/PMC6832484/ /pubmed/31614892 http://dx.doi.org/10.3390/jcm8101672 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Grąt, Karolina
Pacho, Ryszard
Grąt, Michał
Krawczyk, Marek
Zieniewicz, Krzysztof
Rowiński, Olgierd
Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation
title Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation
title_full Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation
title_fullStr Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation
title_full_unstemmed Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation
title_short Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation
title_sort impact of body composition on the risk of hepatocellular carcinoma recurrence after liver transplantation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832484/
https://www.ncbi.nlm.nih.gov/pubmed/31614892
http://dx.doi.org/10.3390/jcm8101672
work_keys_str_mv AT gratkarolina impactofbodycompositionontheriskofhepatocellularcarcinomarecurrenceafterlivertransplantation
AT pachoryszard impactofbodycompositionontheriskofhepatocellularcarcinomarecurrenceafterlivertransplantation
AT gratmichał impactofbodycompositionontheriskofhepatocellularcarcinomarecurrenceafterlivertransplantation
AT krawczykmarek impactofbodycompositionontheriskofhepatocellularcarcinomarecurrenceafterlivertransplantation
AT zieniewiczkrzysztof impactofbodycompositionontheriskofhepatocellularcarcinomarecurrenceafterlivertransplantation
AT rowinskiolgierd impactofbodycompositionontheriskofhepatocellularcarcinomarecurrenceafterlivertransplantation